Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Eflapegrastim Xnst 13.2 Mg/0.6 Ml Sol [Bchc] (CDM 27833268) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 26, 2026 , from http://ppman.hank.ai/transparency/procedure/27833268/by-state?code_type=CDM
“Eflapegrastim Xnst 13.2 Mg/0.6 Ml Sol [Bchc] (CDM 27833268) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/27833268/by-state?code_type=CDM. Accessed
October 26, 2026 .
“Eflapegrastim Xnst 13.2 Mg/0.6 Ml Sol [Bchc] (CDM 27833268) by State,” HANK Price Transparency ,
accessed October 26, 2026 ,
http://ppman.hank.ai/transparency/procedure/27833268/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
27833268 — Eflapegrastim Xnst 13.2 Mg/0.6 Ml Sol [Bchc]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$6,774
National median
$6,020 – $6,827
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 27833268 (CDM), with interquartile range
State Median p25 p75
NE $6,774 $6,020 $6,827